These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22555345)
1. The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma. Jamieson NB; Mohamed M; Oien KA; Foulis AK; Dickson EJ; Imrie CW; Carter CR; McKay CJ; McMillan DC Ann Surg Oncol; 2012 Oct; 19(11):3581-90. PubMed ID: 22555345 [TBL] [Abstract][Full Text] [Related]
2. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma. La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324 [TBL] [Abstract][Full Text] [Related]
4. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer. Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553 [TBL] [Abstract][Full Text] [Related]
5. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival. Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217 [TBL] [Abstract][Full Text] [Related]
7. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532 [TBL] [Abstract][Full Text] [Related]
8. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer. Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671 [TBL] [Abstract][Full Text] [Related]
9. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas. Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990 [TBL] [Abstract][Full Text] [Related]
10. Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Jamieson NB; Foulis AK; Oien KA; Dickson EJ; Imrie CW; Carter R; McKay CJ J Gastrointest Surg; 2011 Mar; 15(3):512-24. PubMed ID: 21116727 [TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of extracapsular lymph node involvement in pancreatic ductal adenocarcinoma. Sergeant G; Ectors N; Fieuws S; Aerts R; Topal B Ann Surg Oncol; 2009 Nov; 16(11):3070-9. PubMed ID: 19649555 [TBL] [Abstract][Full Text] [Related]
13. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma. An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471 [TBL] [Abstract][Full Text] [Related]
14. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients. Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725 [TBL] [Abstract][Full Text] [Related]
15. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma. Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403 [TBL] [Abstract][Full Text] [Related]
16. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection. Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836 [TBL] [Abstract][Full Text] [Related]
17. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601 [TBL] [Abstract][Full Text] [Related]
18. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease. Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion. Lenz J; Karasek P; Jarkovsky J; Muckova K; Dite P; Kala Z; Veselska R; Hermanova M J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705 [TBL] [Abstract][Full Text] [Related]
20. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. Shimada K; Sakamoto Y; Sano T; Kosuge T J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]